108 148
[25]
Tillou X, Chahwan C, Le Gal S, Bensadoun H, Doer fl er A. Prostatec- tomy for localized prostate cancer to prepare for renal transplanta- tion in end-stage renal disease patients. Ann Transplant 2014;19: 569 – 75.[26]
Yiou R, Salomon L, Colombel M, Patard JJ, Chopin D, Abbou CC. Perineal approach to radical prostatectomy in kidney transplant recipients with localized prostate cancer. Urology 1999;53: 822 – 4.
[27]
Ryosaka M, Ishida H, Takagi T, Shimizu T, Tanabe K, Kondo T. Solid-type RCC originating from native kidneys in renal transplant recipients should be monitored cautiously. Transpl Int 2015;28: 813 – 9.
[28]
Savaj S, Liakopoulos V, Ghareeb S, et al. Renal cell carcinoma in peritoneal dialysis patients. Int Urol Nephrol 2003;35:263 – 5.
[29]
Joshi R, Mammen K, Pawar B. Successful renal transplantation after two separate urinary tract malignancies. Indian J Urol 2008;24: 256 – 7.
[30]
Takagi T, Kondo T, Okumi M, Ishida H, Tanabe K. Differences in clinical and pathological features of renal cell carcinoma between Japanese patients after kidney transplantation and those on hemo- dialysis. Ther Apher Dial 2017;21:133 – 8.
[31]
Shrewsberry AB, Osunkoya AO, Jiang K, et al. Renal cell carcinoma in patients with end-stage renal disease has favorable overall progno- sis. Clin Transplant 2014;28:211 – 6.[32]
Hora M, Hes O, Reischig T, et al. Tumours in end-stage kidney. Transplant Proc 2008;40:3354 – 8.
[33]
Kojima Y, Takahara S, Miyake O, Nonomura N, Morimoto A, Mori H. Renal cell carcinoma in dialysis patients: a single center experience. Int J Urol 2006;13:1045 – 8.
[34]
Peces R, Martínez-Ara J, Miguel JL, et al. Renal cell carcinoma co- existent with other renal disease: clinico-pathological features in pre-dialysis patients and those receiving dialysis or renal trans- plantation. Nephrol Dial Transplant 2004;19:2789 – 96.[35]
Stiles KP, Moffatt MJ, Agodoa LY, Swanson SJ, Abbott KC. Renal cell carcinoma as a cause of end-stage renal disease in the United States: patient characteristics and survival. Kidney Int 2003;64:247 – 53.[36]
Gulanikar AC, Daily PP, Kilambi NK, Hamrick-Turner JE, Butkus DE. Prospective pretransplant ultrasound screening in 206 patients for acquired renal cysts and renal cell carcinoma. Transplantation 1998;66:1669 – 72.
[37]
Shingleton WB, Blalock J, Clark J, Bigler SA. Renal cell carcinoma in native kidneys of patients with end stage renal disease. J Miss State Med Assoc 1998;39:86 – 9.[38]
Chahwan C, Doer fl er A, Brichart N, et al. Prostate cancer before renal transplantation: a multicentre study. Prog Urol 2017;27:166 – 75.
[39]
Schonberger B. Bladder dysfunction and surgery in the small pelvis. Therapeutic possibilities. Urologe A 2003;42:1569 – 75.[40]
Özçelik Ü, Bircan HY, Karakayal ǵ F, Moray G, Demirag A. Delaying renal transplant after radical prostatectomy for low-risk prostate cancer. Exp Clin Transplant 2015;13(Suppl 3):74 – 6.[41]
Kocak B, Bilen CY, Dilek M, Adibelli Z, Akpolat T, Sarikaya S. Is localized prostate cancer an obstacle for an immediate consider- ation for renal transplantation?. A case report. Transplant Proc 2009;41:1961 – 2.[42]
Chang C-H, Yang C-M, Yang A-H. Renal diagnosis of chronic hemo- dialysis patients with urinary tract transitional cell carcinoma in Taiwan. Cancer 2007;109:1487 – 92.
[43]
Hung P-H, Shen C-H, Chiu Y-L, et al. The aggressiveness of urinary tract urothelial carcinoma increases with the severity of chronic kidney disease. BJU Int 2009;104:1471 – 4.[44]
Li C-E, Chien C-S, Chuang Y-C, Chang Y-I, Tang H-P, Kang C-H. Chronic kidney disease as an important risk factor for tumour recurrences, progression and overall survival in primary non-mus- cle-invasive bladder cancer. Int Urol Nephrol 2016;48:993 – 9.
[45]
Ou JH, Pan CC, Lin JS, et al. Transitional cell carcinoma in dialysis patients. Eur Urol 2000;37:90 – 4.
[46]
Chapman JR, Sheil AG, Disney AP. Recurrence of cancer after renal transplantation. Transplant Proc 2001;33:1830 – 1.
[47]
Juric I, Basic-Jukic N. Testicular seminoma occurring after kidney transplantation in a patient previously treated for teratoma: de novo malignancy or recurrence in a different histologic form? Transplant Proc 2016;48:3128 – 9.E U R O P E A N U R O L O GY 7 3 ( 2 0 18 ) 9 4
–
10 8
108